245 related articles for article (PubMed ID: 24599677)
1. Visualization of DAS28, SDAI, and CDAI: the magic carpets of rheumatoid arthritis.
Futó G; Somogyi A; Szekanecz Z
Clin Rheumatol; 2014 May; 33(5):623-9. PubMed ID: 24599677
[TBL] [Abstract][Full Text] [Related]
2. How much does Disease Activity Score in 28 joints ESR and CRP calculations underestimate disease activity compared with the Simplified Disease Activity Index?
Fleischmann R; van der Heijde D; Koenig AS; Pedersen R; Szumski A; Marshall L; Bananis E
Ann Rheum Dis; 2015 Jun; 74(6):1132-7. PubMed ID: 25143522
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: the role of acute-phase reactants.
Smolen JS; Aletaha D
Arthritis Rheum; 2011 Jan; 63(1):43-52. PubMed ID: 21204103
[TBL] [Abstract][Full Text] [Related]
4. Differences in disease activity measures in patients with rheumatoid arthritis who achieved DAS, SDAI, or CDAI remission but not Boolean remission.
Aletaha D; Wang X; Zhong S; Florentinus S; Monastiriakos K; Smolen JS
Semin Arthritis Rheum; 2020 Apr; 50(2):276-284. PubMed ID: 31590930
[TBL] [Abstract][Full Text] [Related]
5. Performances of Clinical Disease Activity Index (CDAI) and Simplified Disease Activity Index (SDAI) appear to be better than the gold standard Disease Assessment Score (DAS-28-CRP) to assess rheumatoid arthritis patients.
Dhaon P; Das SK; Srivastava R; Dhakad U
Int J Rheum Dis; 2018 Nov; 21(11):1933-1939. PubMed ID: 28608433
[TBL] [Abstract][Full Text] [Related]
6. Test-retest reliability of the disease activity score 28 CRP (DAS28-CRP), the simplified disease activity index (SDAI) and the clinical disease activity index (CDAI) in rheumatoid arthritis when based on patient self-assessment of tender and swollen joints.
Heegaard C; Dreyer L; Egsmose C; Madsen OR
Clin Rheumatol; 2013 Oct; 32(10):1493-500. PubMed ID: 23754243
[TBL] [Abstract][Full Text] [Related]
7. DAS28, CDAI and SDAI cut-offs do not translate the same information: results from the Rheumatic Diseases Portuguese Register Reuma.pt.
Martins FM; da Silva JA; Santos MJ; Vieira-Sousa E; Duarte C; Santos H; Costa JA; Pimentel-Santos FM; Cunha I; Cunha Miranda L; Nóvoa T; Cruz M; Bernardes M; Araujo D; Pereira Silva JA; Silva JC; Branco JC; Gomes JA; Faustino A; Fonseca JE; Canhão H
Rheumatology (Oxford); 2015 Feb; 54(2):286-91. PubMed ID: 25173347
[TBL] [Abstract][Full Text] [Related]
8. American College of Rheumatology/European League Against Rheumatism remission criteria for rheumatoid arthritis maintain reliable performance when evaluated in 44 joints.
Kaneko Y; Kondo H; Takeuchi T
J Rheumatol; 2013 Aug; 40(8):1254-8. PubMed ID: 23772077
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of four assessment criteria for disease activity of rheumatoid arthritis].
Cen XM; Liang Y; Xie QB; Yang M; Yin G
Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 46(2):280-4. PubMed ID: 25924446
[TBL] [Abstract][Full Text] [Related]
10. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score.
Aletaha D; Nell VP; Stamm T; Uffmann M; Pflugbeil S; Machold K; Smolen JS
Arthritis Res Ther; 2005; 7(4):R796-806. PubMed ID: 15987481
[TBL] [Abstract][Full Text] [Related]
11. The comparative responsiveness of the patient self-report questionnaires and composite disease indices for assessing rheumatoid arthritis activity in routine care.
Salaffi F; Ciapetti A; Gasparini S; Carotti M; Bombardieri S;
Clin Exp Rheumatol; 2012; 30(6):912-21. PubMed ID: 22935335
[TBL] [Abstract][Full Text] [Related]
12. Performance of Routine Assessment of Patient Index Data 3 (RAPID3) for assessment of rheumatoid arthritis in clinical practice: differential agreement of RAPID3 according to disease activity categories.
Kim SK; Park SH; Bae J; Son JT; Choe JY
Rheumatol Int; 2014 Sep; 34(9):1311-8. PubMed ID: 24832679
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of newly proposed remission cut-points for disease activity score in 28 joints (DAS28) in rheumatoid arthritis patients upon IL-6 pathway inhibition.
Schoels M; Alasti F; Smolen JS; Aletaha D
Arthritis Res Ther; 2017 Jul; 19(1):155. PubMed ID: 28676129
[TBL] [Abstract][Full Text] [Related]
14. Comparison of composite disease activity indices for rheumatoid arthritis.
Matsui T; Kuga Y; Nishino J; Kaneko A; Eto Y; Tohma S
Mod Rheumatol; 2011 Apr; 21(2):134-43. PubMed ID: 20972600
[TBL] [Abstract][Full Text] [Related]
15. Performance of routine assessment of patient index data 3 (RAPID3) in monitoring disease activity of Chinese rheumatoid arthritis patients.
Zhang X; Xie A; Wang Y; Deng X; Geng Y; Ji L; Hao Y; Li G; Zhang Z
Int J Rheum Dis; 2018 Nov; 21(11):1940-1945. PubMed ID: 30402934
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of disease activity indices in Korean patients with rheumatoid arthritis.
Park SY; Lee H; Cho SK; Choi CB; Sung YK; Bae SC
Rheumatol Int; 2012 Feb; 32(2):545-9. PubMed ID: 21305296
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of feet and ankle arthritis and their impact on clinical indices in patients with rheumatoid arthritis: a cross-sectional study.
Lee SW; Kim SY; Chang SH
BMC Musculoskelet Disord; 2019 Sep; 20(1):420. PubMed ID: 31506089
[TBL] [Abstract][Full Text] [Related]
18. Association between Novel Hematological Indices and Measures of Disease Activity in Patients with Rheumatoid Arthritis.
Choe JY; Lee CU; Kim SK
Medicina (Kaunas); 2023 Jan; 59(1):. PubMed ID: 36676741
[TBL] [Abstract][Full Text] [Related]
19. Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis.
Klarenbeek NB; Koevoets R; van der Heijde DM; Gerards AH; Ten Wolde S; Kerstens PJ; Huizinga TW; Dijkmans BA; Allaart CF
Ann Rheum Dis; 2011 Oct; 70(10):1815-21. PubMed ID: 21813548
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the validity of the 28-joint disease activity score using erythrocyte sedimentation rate (DAS28-ESR) as a disease activity index of rheumatoid arthritis in the efficacy evaluation of 24-week treatment with tocilizumab: subanalysis of the SATORI study.
Nishimoto N; Takagi N
Mod Rheumatol; 2010 Dec; 20(6):539-47. PubMed ID: 20617358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
